| Accession |
PRJCA023071 |
| Title |
A Clinical Study of GC012F Injection |
| Relevance |
Medical |
| Data types |
Proteomic Date
|
| Organisms |
Homo sapiens
|
| Description |
Principal study objective:To evaluate the safety of GC012F Injection in the treatment of relapsed/refractory BCMA + multiple myeloma.Secondary study objectives1)To evaluate the efficacy of GC012F Injection in the treatment of relapsed/refractory BCMA + multiple myeloma;2)And to evaluate the in vivo proliferation, survival and immunogenicity of GC012F Injection in subjects. |
| Sample scope |
Synthetic |
| Release date |
2024-01-24 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| No funding support
|
|
|
|
|
|
| Submitter |
mingyue
xiang (mingyue.xiang@gracellbio.com)
|
| Organization |
Gracell Biotechnologies Inc |
| Submission date |
2024-01-22 |
